SES
10.4.2018 18:02:11 CEST | Business Wire | Press release
Following major space and ground infrastructure investments and the expansion of its Latin America video neighbourhood, SES today announced the launch of its Ultra HD platform into the region to accelerate commercial 4K rollouts among leading cable, IPTV, and DTH providers across Latin America.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180410006195/en/
Many of Latin America’s leading Pay TV providers are already testing SES’s new Ultra HD solution, an all-in-one package of pre-configured Ultra HD content, reception equipment, and satellite distribution that will enable quick and easy Ultra HD deployments over the region. The new SES Latin America Ultra HD solution will open with four Ultra HD channels, including NASA TV UHD, produced by Harmonic, as well as the SES Ultra HD demo channel, an incubator for emerging 4K content producers. SES plans to add new channels and content produced in Brazil, Mexico, and other Latin American countries in the future.
Like SES’s North America Ultra HD solution, the end-to-end Latin America platform will be distributed over multiple SES satellites. SES-6 will provide dedicated delivery across 100% of the Brazilian market, offering programming flexibility for local content. SES’s NSS-806 satellite, home to SES’s leading Latin American Pay TV neighbourhood, will serve the rest of the region until it is replaced by the recently launched SES-14 satellite later this year. Once SES-14 initiates service, SES plans to significantly expand the Latin America channel lineup on its expanding video neighbourhood at 47.5 West. SES is the unmatched leader in global HD and Ultra HD distribution, and has experienced unprecedented 18% year-on-year growth in Latin America with over 300 HD and Ultra HD channels currently hosted on its satellites.
“SES is ushering in an exciting new era of advanced television services across the region with the launch of our new Latin America Ultra HD platform – the latest game-changing solution built on SES’s robust network of space and ground infrastructure. The SES network is enabling the efficient delivery of HD, Ultra HD, and OTT content to audiences throughout the region,” said Jurandir Pitsch, Vice President, Sales and Market Development for SES Video in Latin America and the Caribbean. “Latin America’s leading Pay TV providers are poised to offer Ultra HD content to their subscribers via the SES platform ahead of the 2018 World Cup, which is driving strong interest in 4K services across the region.”
The SES-backed antenna programme, which led to the installation of satellite antennas at Pay TV distribution hubs throughout Latin America, puts SES in a prime position to help cable, IPTV and DTH providers reach 100% of the region’s vast audiences with advanced HD and Ultra HD content.
Learn more about the SES UHD platform
Follow us on:
About SES
SES is the world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 16 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in two key business units: SES Video and SES Networks. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions. SES’s portfolio includes ASTRA, O3b and MX1, a leading media service provider that offers a full suite of innovative digital video and media services. SES is listed on the Euronext Paris and Luxembourg Stock Exchange (ticker: SESG). Further information available at: www.ses.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180410006195/en/
Contact:
SES
Markus Payer
Corporate Communications & PR
Tel.
+352 710 725 500
Markus.Payer@ses.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 09:20:00 CEST | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release
STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release
Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria
Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom